Skip to main content
. 2016 Aug 3;25(14):1587–1596. doi: 10.1177/0961203316655215

Table 2.

Time to first flare

Concomitant medications group Treatment arm Probability of an event (95% CI) by Week 52, % Hazard ratio (95% CI)
Steroids only Placebo (n = 61) 78.1 (67.0, 87.6) 0.64 (0.42, 0.96)
Belimumab 10 mg/kg (n = 78) 64.3 (53.6, 74.9)
AM only Placebo (n = 32) 84.4 (70.0, 94.3) 0.82 (0.48, 1.38)
Belimumab 10 mg/kg (n = 45) 81.6 (68.3, 91.8)
Steroids + AM Placebo (n = 186) 80.3 (74.2, 85.8) 0.83 (0.65, 1.06)
Belimumab 10 mg/kg (n = 160) 71.2 (63.9, 78.2)
Steroids + AM + IS Placebo (n = 139) 87.9 (81.7, 92.7) 0.81 (0.62, 1.05)
Belimumab 10 mg/kg (n = 133) 82.3 (75.3, 88.3)

AM: antimalarial; CI: confidence interval; IS: immunosuppressant.